| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.92B | 101.01B | 92.33B | 94.51B | 76.09B | 62.85B |
| Gross Profit | 22.40B | 21.26B | 17.92B | 19.21B | 17.98B | 14.96B |
| EBITDA | 6.10B | 5.63B | 3.06B | 5.22B | 5.44B | 4.93B |
| Net Income | 791.00M | 763.00M | -1.16B | 885.73M | 1.75B | 1.09B |
Balance Sheet | ||||||
| Total Assets | 101.00B | 100.04B | 98.58B | 92.44B | 78.91B | 69.39B |
| Cash, Cash Equivalents and Short-Term Investments | 4.93B | 4.75B | 6.85B | 6.30B | 6.63B | 3.48B |
| Total Debt | 42.03B | 42.56B | 39.37B | 33.67B | 21.50B | 17.68B |
| Total Liabilities | 64.06B | 62.03B | 57.70B | 51.62B | 38.80B | 31.95B |
| Stockholders Equity | 36.27B | 37.33B | 37.22B | 37.10B | 36.74B | 34.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 684.00M | -3.08B | -4.80B | -22.99M | 712.74M |
| Operating Cash Flow | 0.00 | 6.14B | 353.00M | -466.24M | 2.83B | 3.01B |
| Investing Cash Flow | 0.00 | -4.98B | -3.20B | -6.65B | -3.44B | -1.86B |
| Financing Cash Flow | 0.00 | -3.67B | 2.90B | 7.66B | 2.11B | -1.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥27.24B | 16.70 | ― | 3.63% | 18.02% | 18.04% | |
69 Neutral | ¥15.49B | 9.04 | ― | 3.23% | 13.09% | 89.45% | |
66 Neutral | ¥28.61B | 12.59 | ― | 3.84% | -3.41% | -12.83% | |
66 Neutral | ¥16.12B | 13.16 | ― | 2.78% | 1.30% | -5.03% | |
66 Neutral | ¥24.91B | 13.05 | ― | 4.62% | 7.19% | ― | |
64 Neutral | ¥25.93B | 14.95 | ― | 4.27% | 5.72% | 28.92% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
Harima Chemicals Group has revised its fiscal 2025 consolidated earnings forecast, leaving net sales unchanged at ¥108 billion but substantially raising profit projections, with operating income expected to rise to ¥3.3 billion, ordinary income to ¥2.8 billion, and net income attributable to the parent to ¥1.85 billion. The company cited stronger-than-expected performance in its Resins and Tall Oil Products business driven by new paint resin products, as well as robust demand in its Electronic Materials division for resins used in semiconductor resists, offsetting weaker sales in Paper Chemicals in Japan and China and lower-than-anticipated volumes in the Lawter business due to a sluggish recovery in Europe and the U.S.; as a result, profitability is now forecast to grow significantly year on year, signaling improved earnings efficiency despite flat overall sales.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1008.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group reported steady topline growth and sharply improved profitability for the third quarter of the fiscal year ending March 31, 2026, with net sales up 2.9% year on year to ¥77.9 billion and net income attributable to the parent more than doubling, rising 149.2% to ¥1.8 billion. Operating income climbed 36.8% to ¥2.7 billion and ordinary income rose 63.5%, while total assets increased to ¥103.3 billion and equity also improved, indicating a stronger balance sheet. The company maintained its interim dividend at ¥21 per share and kept the full-year dividend forecast at ¥42, and it upgraded its full-year earnings outlook, now projecting net sales of ¥108 billion and a 142.5% jump in full-year net income to ¥1.85 billion, signaling improved operational efficiency and a more optimistic earnings trajectory for shareholders despite only modest sales growth. The consolidation scope, accounting policies, and capital structure remained largely unchanged, underscoring that the performance improvement is driven primarily by core operations rather than structural changes.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen1008.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.
Harima Chemicals Group, Inc. announced changes in its senior personnel, effective January 1, 2026, following a Board of Directors’ meeting. These changes include new appointments for key positions within the company, which may influence its strategic direction and operational efficiency, particularly in its paper chemicals division.
The most recent analyst rating on (JP:4410) stock is a Hold with a Yen951.00 price target. To see the full list of analyst forecasts on Harima Chemicals Group, Inc. stock, see the JP:4410 Stock Forecast page.